Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renexin in Recurrent Vestibulopathy
NCT01895400Phase 3Terminated
- Start
- Jul 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol + ginkgo leaf extract in recurrent vestibulopathy (RV). Started Jul 2013; status: terminated.
02
Drugs
cilostazol + ginkgo leaf extract
03
Conditions
recurrent vestibulopathy (RV)
Beyond the preview
Go deeper on NCT01895400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895400.